U-Systems, Inc. announces technology licensing agreement with
Siemens Healthcare
31 December 2008
U-Systems, Inc has announced a technology licensing agreement with
the Ultrasound Business Unit of Siemens Medical Solutions USA, Inc.
The U-Systems’ somo•VIEWer advanced workstation for Automated Breast
Ultrasound has been licensed for use with the newly introduced Siemens’
ACUSON S2000 Automated Breast Volume Scanner (ABVS).
This will allow physicians to obtain the comprehensive 3D view of the
breast volume which features U-Systems’ intuitive anatomical coronal
plane not available with conventional ultrasound systems.
"This license agreement will increase the adoption of automated
breast ultrasound systems for women’s healthcare clinics wanting the
most advanced imaging technologies," said Ron Ho, President and CEO of
U-Systems.
"Women’s healthcare and breast imaging is strategic to both U-Systems
and Siemens. We see significant advantages in leveraging Siemens’
marketing and ultrasound expertise with our advanced development
competencies and look forward to this partnership.”
Siemens is a non-exclusive distributor for U-Systems’ technology and
products, including the somo•v Automated 3D Breast Ultrasound System,
somo•VIEWer Software & Workstation, and somo•v Patient Stabilizing
Membranes.
“I am convinced that automated breast volume scanning can make a
significant contribution in diagnostic confidence for women with dense
breast tissue and inconclusive mammograms,” said Klaus Hambuechen, CEO,
Ultrasound, Siemens Healthcare. “The coronal view provided by the
somo•VIEWer offers a more understandable representation of the global
anatomy and architecture of the breast, which will ultimately improve
patient care and increase clinical workflow.”
U-Systems is dedicated to bringing technology solutions to women’s
healthcare. In 2009, the company will be sponsoring a multi-center
breast cancer screening study, somo•InSIGHT, with more than 20,000 women
using its proprietary Automated Breast Ultrasound System (ABUS). The
clinical study will evaluate the sensitivity and specificity of X-Ray
Mammography (XRM) and Automated Breast Ultrasound (ABUS) together as
compared to XRM alone, as a breast cancer screening method in women with
greater than 50 percent parenchymal density.
Bookmark this page